Adaptive Biotechnologies, Seattle, WA

Adaptive Biotechnologies

www.adaptivebiotech.com

Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people`s lives by learning from the wisdom of their adaptive immune systems. Adaptive`s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases -- such as cancer, autoimmune conditions, and infectious diseases -- are diagnosed and treated.

Number of Employees: 250-1000
Annual Revenue: $50-100 Million

www.adaptivebiotech.com
1551 Eastlake Avenue East Suite 200
Seattle, WA USA 98102
Phone: 206.659.0067

Name	Title	Contact Details
David Arbo	Sr Director of Information Technology	Profile
Josh Schmidt	Senior Director, Information Security	Profile
Mark Adams	Chief Technical Officer	Profile
Mark Adams	Chief Operating Officer	Profile

Similar Companies

Advitech

Advitech is a Quebec, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rosetta Genomics

Founded in 2000, Rosetta's integrative research platform combining bioinformatics and state-of- the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta is working on the application of these technologies in the development and commercialization of a full range of microRNA-based diagnostic tools and therapeutics. Rosetta currently commercializes a full range of microRNA-based molecular diagnostics. Rosetta's cancer testing services are commercially available through its Philadelphia-based CAP-accredited, CLIA-certified lab.

CTOs on the Move